Biogened Cash Flow Statement

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	4.62	5.82	5.1	3.38	1.96
Depreciation & Amortization	4.37	4.13	3.52	2.94	2.88
Other Adjustments	1.79	2.53	2.42	1.8	0.39
Change in Receivables	-2.22	-1.57	-0.42	4.07	-2.1
Changes in Inventories	6.25	-7.02	1.15	-8.14	0.61
Changes in Accounts Payable	-1.47	0.87	3.56	3.51	2.15
Changes in Accrued Expenses	-0.87	-0.78	-0.46	-1.55	-1.78
Operating Cash Flow	12.47	4	14.87	6.01	3.14
Operating Cash Flow Growth	212.18%	-73.13%	147.34%	91.42%	-63.93%
Capital Expenditures	-7.35	-5.49	-7.15	-9.36	-1.57
Sale of Property, Plant & Equipment	0.42	0	0	0	-0
Proceeds from Sale of Investments	0	0	0	0	0.49
Investing Cash Flow	-6.93	-5.49	-7.15	-9.36	-1.08
Long-Term Debt Issued	3.87	7.7	2.34	5.56	5.84
Long-Term Debt Repaid	5.11	3.2	3.86	3.6	4.54
Net Long-Term Debt Issued (Repaid)	8.98	10.9	6.2	9.16	10.38
Common Dividends Paid	1.23	1.23	0.98	0.74	0.49
Other Financing Activities	-2.82	-3.23	-1.16	0.61	-0.45
Financing Cash Flow	-5.29	0.05	-3.66	1.84	0.36
Net Cash Flow	0.25	-1.44	4.06	-1.51	2.42
Free Cash Flow	5.13	-1.49	7.72	-3.35	1.57
Free Cash Flow Growth	-	-	-	-	-77.12%
FCF Margin	4.49%	-1.35%	8.08%	-4.21%	2.41%
Free Cash Flow Per Share	2.09	-0.61	3.14	-1.36	0.64
Levered Free Cash Flow	14.53	8.44	11.92	-0.06	14.63
Unlevered Free Cash Flow	7.32	-1.47	7.31	-8.15	3.62